[ad_1]
class = “cf”>
Uğur Şahin, who gave hope to the world with the vaccine he developed with his wife Özlem Türeci against the coronavirus, made statements to German television RTL about the course of the epidemic and vaccination.
Emphasizing that the growing number of cases in Europe is concerning, Uğur Şahin said that available vaccines should be used as soon as possible rather than stocked up. “The risk of vaccination interruption is very low due to a delay in supply,” said Şahin. That is why you must do all the vaccines you have, with the certainty that new vaccines will arrive every week ”.
class = “cf”>
THE NUMBER OF CASES SHOULD BE KEPT LOW
“Unfortunately, the number of infections in Germany and Europe has increased so much that we can no longer wait for the new restrictions to take effect,” said Uğur Şahin, “The biggest challenge for the next three to four months will be keeping the number of cases. “Rising temperatures may reduce the number of infections, but if not, we may experience a more difficult shutdown in the summer.” Saying that if vaccines are shipped as planned and vaccination is accelerated, it is possible “return to normalization” at the end of the summer months and a new closure can be prevented in the coming winter months.
SCHOOLS CLOSED IN FRANCE
Meanwhile, measures have been partially relaxed in Britain, which leads vaccination, while measures have been further tightened in France. Curfew restrictions imposed in some regions, including the capital Paris, will apply to the entire country from Saturday. In addition, the schools were also on vacation for three weeks. In announcing the decisions, President Emmanuel Macron said: “If we do not act now, we will lose control.” On the other hand, German Chancellor Angela Merkel and Macron, who are trying to speed up vaccination, discussed the possibilities of cooperation in vaccination with Russian leader Vladimir Putin.
BY OPENING A NEW FACILITY, BIONTECH INCREASES PRODUCTION
class = “cf”>
The BioNTech company, which has activated its facilities in Marburg, Germany, with the approval of the European Medicines Agency (EMA), has increased its target for the production of vaccines against the coronavirus. The vaccine production target, which was set at 2.3 billion doses for this year, increased to 2.5 billion doses with the new facility. To maximize production capacity, the first batch of vaccines produced at the facility, where 400 employees work 24 hours a day, 7 days a week, is expected to be delivered in the second half of April. The facility is expected to produce 1 billion doses of vaccine annually when fully operational. Vaccines produced in Marburg are shipped to countries after sterile filling and packaging at bottling centers in various parts of Europe.
THE THIRD LARGEST PHARMACEUTICAL COMPANY
BioNTech, in partnership with the US pharmaceutical company Pfizer, ships the coronavirus vaccine to 65 countries around the world. Founded in 2008, the company outperformed Germany’s established pharmaceutical companies. It was claimed that BioNTech, with an estimated turnover of € 9.8 billion in 2021, could become Germany’s third-largest pharmaceutical company after Bayer and Boehringer.
Bigpara for crypto money markets
Bigpara for crypto money markets
